News from pdl biopharma, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 18, 2014, 16:09 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Second Quarter 2014 and Year to Date Financial Results

  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the second quarter and six months ended June 30,...

Aug 18, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Plans to Issue Second Quarter Financial Results After Market Today and Reschedules Earnings Call for Tuesday, August 19 at 4:30pm EDT

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will issue its second quarter financial results after market today and...

Aug 08, 2014, 15:20 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Delay in Filing Quarterly Report on Form 10-Q

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company has filed a Form 12b-25 Notification of Late Filing with the U.S....

Jul 30, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will participate in the Jefferies 2014 Boston Healthcare...

Jul 28, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its second quarter 2014 financial results for the period...

Jun 24, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Participate in Upcoming Investor Conferences

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will...

Jun 12, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Completes Regular Quarterly Dividend Payment

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the June 12, 2014, regular quarterly dividend payment of $0.15 per...

Jun 10, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Provides Second Quarter 2014 Revenue Guidance of $140 Million

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the second quarter ending June 30, 2014, of approximately $140...

Jun 04, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: - 3.75% Convertible Senior Notes...

May 29, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will...

May 12, 2014, 16:01 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces First Quarter 2014 Financial Results

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2014. Total revenues for the...

May 08, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that Peter Garcia, the company's vice president and chief financial officer, will present...

May 07, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Announce First Quarter 2014 Financial Results on May 12, 2014

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its first quarter 2014 financial results for the period...

May 06, 2014, 09:28 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

European Patent Office Names Inventors of PDL BioPharma's Antibody Technology as Finalists for European Inventor Award for 2014

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that two inventors of the company's patented breakthrough  antibody technology...

Apr 07, 2014, 07:00 ET

PDL BioPharma Completes $150 Million Financing Transaction with kaleo

 PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has acquired $150 million of Notes due 2029 (the Notes) from Accel 300, LLC, a...

Mar 13, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2014

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will hold its annual meeting of stockholders on Wednesday, May 28, 2014,...

Mar 12, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Completes Regular Quarterly Dividend Payment

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 12, 2014, regular quarterly dividend payment of $0.15...

Mar 11, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Provides First Quarter 2014 Revenue Guidance of $133 Million

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the first quarter ending March 31, 2014, of approximately $133...

Mar 10, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Appoints David Gryska to its Board of Directors

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced the appointment of David W. Gryska to its board of directors.  Mr. Gryska brings...

Mar 04, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: - 3.75% Convertible Senior Notes due May...